HighPoint Advisor Group’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-28,427
Closed -$1.34M 505
2020
Q3
$1.34M Sell
28,427
-54,245
-66% -$211K 0.24% 84
2020
Q2
$1.21M Sell
82,672
-387
-0.5% -$710 0.26% 80
2020
Q1
$1.16M Sell
83,059
-88
-0.1% -$84 0.28% 73
2019
Q4
$1.06M Sell
83,147
-30,767
-27% -$33.9K 0.22% 87
2019
Q3
$510K Buy
113,914
+62,085
+120% +$85.7K 0.11% 154
2019
Q2
$392K Buy
51,829
+4,873
+10% +$7.76K 0.09% 190
2019
Q1
$221K Buy
+46,956
New +$58K 0.05% 294

Other funds holding TLSA

HighPoint Advisor Group's TLSA Position: Q4 2020 in Review

HighPoint Advisor Group sold out of Tiziana Life Sciences (TLSA) in Q4 2020, closing a stake of 28,427 shares — an estimated $1.34M sold.

HighPoint Advisor Group first reported a position in TLSA in Q1 2019 and held it in 7 quarters. The position peaked at $1.34M in Q3 2020. 24 funds tracked by Wall St. Rank hold TLSA as of Q4 2020.

  • HighPoint Advisor Group reported no remaining Tiziana Life Sciences position as of Q4 2020 after selling out during the quarter.
  • HighPoint Advisor Group sold 28,427 Tiziana Life Sciences shares in Q4 2020, an estimated $1.34M.
  • HighPoint Advisor Group first reported a position in Tiziana Life Sciences in Q1 2019 and held it in 7 quarters.
  • HighPoint Advisor Group's Tiziana Life Sciences position peaked at $1.34M in Q3 2020.
  • 24 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2020.

Based on HighPoint Advisor Group's 13F filing for Q4 2020, filed 10 Feb 2021.